{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T01:10:35Z","timestamp":1696900235799},"reference-count":14,"publisher":"Wiley","issue":"1-2","license":[{"start":{"date-parts":[[2009,4,24]],"date-time":"2009-04-24T00:00:00Z","timestamp":1240531200000},"content-version":"vor","delay-in-days":4861,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[1996,1,2]]},"abstract":"<jats:p><jats:bold>Abstract: <\/jats:bold> The transfusional need in patients treated with myeloablative chemotherapy appears to be greater than that resulting from bone marrow suppression alone. The erythrocyte transfusional need may be expressed as \u0394hb = the daily loss of haemoglobin (mmol\/1\/day), and multivariate analyses of factors influencing \u0394hb have been carried out. We have studied 124 patients, mainly with acute myeloid leukaemia, treated with 537 courses of chemotherapy, inducing cytopenia (a white cell count &lt; 1.0 times 10<jats:sup>9<\/jats:sup>\/1) in 476 cases. The transfusional need was 2.5\u20133 times greater than expected, suggesting the presence of haemolysis and\/or occult bleedings. Using multiple regression analysis and repeated measurement analysis the main factor influencing the transfusional need was type\/dose of chemotherapy. The higher the dose of cytarabine the greater the transfusional need. Other factors significantly influencing the transfusional need were tumour burden, fever, treatment\u2010related events such as positive blood cultures, systemic fungal infection, mucosal bleeding, melaena\/haematemesis and diarrhoea. Finally, it was found that the transfusional need decreased gradually during the cytopenic period.<\/jats:p>","DOI":"10.1111\/j.1600-0609.1996.tb00288.x","type":"journal-article","created":{"date-parts":[[2010,7,18]],"date-time":"2010-07-18T05:46:24Z","timestamp":1279431984000},"page":"23-29","source":"Crossref","is-referenced-by-count":3,"title":["Influence of selected clinical events on the need for red blood cell transfusion in patients with severe cytopenia following myeloablative chemotherapy"],"prefix":"10.1111","volume":"56","author":[{"given":"L. S.","family":"Friis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. E.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2009,4,24]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI103112"},{"issue":"2","key":"e_1_2_1_3_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1182\/blood.V75.2.518.518","article-title":"Vancomycin\u2010dependent antibodies associated with thrombocytopenia and refractoriness to platelet transfusion in patients with leucaemia","volume":"15","author":"Christie DJ","year":"1990","journal-title":"Blood"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.1990.tb00245.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/161.2.348"},{"key":"e_1_2_1_6_2","first-page":"137","article-title":"The survival of transfused erythrocytes with special reference to cases of acquired haemolytic anaemia","volume":"6","author":"Mollison PL.","year":"1947","journal-title":"Clin Sci"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)70325-4"},{"key":"e_1_2_1_8_2","first-page":"134","volume-title":"Blood Transfusion in Clinical Medicine","author":"Mollison PL","year":"1987"},{"key":"e_1_2_1_9_2","first-page":"64","article-title":"Side effects of intermediate\u2010and high\u2010dose cytosine arabinoside in treatment of refractory or relapsed acute leucaemia and non\u2010Hodgkin's lymphoma","volume":"30","author":"Peters WG","year":"1987","journal-title":"Netherl J Med"},{"key":"e_1_2_1_10_2","first-page":"96","article-title":"Letter to the editor","volume":"44","author":"Hippe E.","year":"1988","journal-title":"Eur J Haematol"},{"key":"e_1_2_1_11_2","first-page":"423","article-title":"The ara\u2010c syndrome, direct endothelial cytotoxicity","volume":"66","author":"Boogaerts MA","year":"1987","journal-title":"Br J Haematol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1969.tb00418.x"},{"key":"e_1_2_1_13_2","unstructured":"JawetzE. MelnickJL AdelbergEA BrooksGF ButelJS OrnstonLN.Medical Microbiology 18th edn.1989 p.133."},{"key":"e_1_2_1_14_2","first-page":"61","article-title":"Dangerous universal donors. I. Observations on destructions of recipient's A cells after transfusions of group O blood containing high titer of A antibodies of immune type not easily neutralizable by soluble A substance","volume":"5","author":"Ervin DM","year":"1950","journal-title":"Blood"},{"key":"e_1_2_1_15_2","unstructured":"CvitkovicE. DrozJP ArmandJP KhouryS.Handbook of Chemotherapy in Clinical Oncology 2nd edn.1993: p.293."}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0609.1996.tb00288.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0609.1996.tb00288.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T08:17:09Z","timestamp":1693383429000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0609.1996.tb00288.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1,2]]},"references-count":14,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[1996,1,2]]}},"alternative-id":["10.1111\/j.1600-0609.1996.tb00288.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0609.1996.tb00288.x","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1,2]]}}}